Stock 24H HANSA BIOPHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Hansa Biopharma AB BOERSE MUENCHEN

Equities

24H

SE0002148817

Market Closed - BOERSE MUENCHEN
Other stock markets
 03:43:58 2024-05-28 pm EDT 		5-day change 1st Jan Change
3.686 EUR +6.66% Intraday chart for Hansa Biopharma AB +3.60% +41.76%
May. 21 Hansa Biopharma to Present Data At 2024 American Transplant Congress Annual Meeting CI
Apr. 18 Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024

Evolution of the average Target Price on Hansa Biopharma AB

Price target over the last 5 years

History of analyst recommendation changes

acf9.g7UXZYytNQaB2NZOBAeyWxDKaeQ3kFQNoVzYW2x3jRk.1eJBKMTqWlXMqu4HbWzIP2qlIYd4xAFF8G2NIiAn2S3KzX0tyZxjRMu3lw~fe09ca32331f50f99169d35e14ae7cb3

Analyst Recommendations on Hansa Biopharma AB

Hansa Biopharma's Follow-up Study Shows High Survival Rate for Imlifidase-enabled Kidney Transplant Patients MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.1 SEK
Average target price
105 SEK
Spread / Average Target
+149.41%
High Price Target
175 SEK
Spread / Highest target
+315.68%
Low Price Target
57 SEK
Spread / Lowest Target
+35.39%

Consensus detail

Consensus revision (last 18 months)

Ratings for Hansa Biopharma AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HNSA Stock
  4. 24H Stock
  5. Consensus Hansa Biopharma AB